nodes	percent_of_prediction	percent_of_DWPC	metapath
Acitretin—ALB—Crohn's disease	0.625	1	CbGaD
Acitretin—RBP1—mouth—Crohn's disease	0.0098	0.148	CbGeAlD
Acitretin—RARG—mouth—Crohn's disease	0.0074	0.112	CbGeAlD
Acitretin—RBP1—epithelium—Crohn's disease	0.0057	0.0862	CbGeAlD
Acitretin—RBP1—smooth muscle tissue—Crohn's disease	0.00549	0.083	CbGeAlD
Acitretin—RBP1—skin of body—Crohn's disease	0.00542	0.082	CbGeAlD
Acitretin—ALB—gall bladder—Crohn's disease	0.00441	0.0666	CbGeAlD
Acitretin—RBP1—digestive system—Crohn's disease	0.00434	0.0656	CbGeAlD
Acitretin—RARG—skin of body—Crohn's disease	0.00409	0.0619	CbGeAlD
Acitretin—RARG—mammalian vulva—Crohn's disease	0.00373	0.0564	CbGeAlD
Acitretin—RARG—digestive system—Crohn's disease	0.00327	0.0495	CbGeAlD
Acitretin—RARA—lymphoid tissue—Crohn's disease	0.00312	0.0471	CbGeAlD
Acitretin—Candida infection—Mercaptopurine—Crohn's disease	0.00257	0.00944	CcSEcCtD
Acitretin—Skin atrophy—Prednisone—Crohn's disease	0.00256	0.00941	CcSEcCtD
Acitretin—RXRG—a6b1 and a6b4 Integrin signaling—MST1—Crohn's disease	0.00256	0.0688	CbGpPWpGaD
Acitretin—Haemorrhoids—Mesalazine—Crohn's disease	0.00248	0.00913	CcSEcCtD
Acitretin—Urine analysis abnormal—Mesalazine—Crohn's disease	0.00248	0.00913	CcSEcCtD
Acitretin—RBP1—lymph node—Crohn's disease	0.00248	0.0374	CbGeAlD
Acitretin—Mouth ulceration—Mercaptopurine—Crohn's disease	0.00243	0.00894	CcSEcCtD
Acitretin—Papilloedema—Prednisone—Crohn's disease	0.00243	0.00893	CcSEcCtD
Acitretin—Thromboembolism—Prednisone—Crohn's disease	0.00243	0.00893	CcSEcCtD
Acitretin—RXRB—a6b1 and a6b4 Integrin signaling—MST1—Crohn's disease	0.0024	0.0647	CbGpPWpGaD
Acitretin—Cyst—Azathioprine—Crohn's disease	0.0024	0.00882	CcSEcCtD
Acitretin—Psoriasis—Mesalazine—Crohn's disease	0.00232	0.00854	CcSEcCtD
Acitretin—RARB—lymph node—Crohn's disease	0.00229	0.0346	CbGeAlD
Acitretin—Nail disorder—Mesalazine—Crohn's disease	0.00225	0.00828	CcSEcCtD
Acitretin—Hypertrichosis—Prednisone—Crohn's disease	0.00203	0.00747	CcSEcCtD
Acitretin—Tongue disorder—Mesalazine—Crohn's disease	0.00201	0.00738	CcSEcCtD
Acitretin—Rigors—Azathioprine—Crohn's disease	0.00196	0.00722	CcSEcCtD
Acitretin—Scotoma—Mesalazine—Crohn's disease	0.00192	0.00707	CcSEcCtD
Acitretin—Rash erythematous—Mesalazine—Crohn's disease	0.00191	0.00701	CcSEcCtD
Acitretin—RARG—lymph node—Crohn's disease	0.00187	0.0283	CbGeAlD
Acitretin—Hyperaesthesia—Mesalazine—Crohn's disease	0.00186	0.00684	CcSEcCtD
Acitretin—Intracranial pressure increased—Prednisone—Crohn's disease	0.00185	0.0068	CcSEcCtD
Acitretin—Impaired healing—Prednisone—Crohn's disease	0.00179	0.00657	CcSEcCtD
Acitretin—RARA—lymph node—Crohn's disease	0.00176	0.0266	CbGeAlD
Acitretin—Acne—Mesalazine—Crohn's disease	0.00174	0.00638	CcSEcCtD
Acitretin—Breast pain—Mesalazine—Crohn's disease	0.00167	0.00615	CcSEcCtD
Acitretin—Proteinuria—Mesalazine—Crohn's disease	0.00166	0.00611	CcSEcCtD
Acitretin—Pancreatitis—Mercaptopurine—Crohn's disease	0.00166	0.00608	CcSEcCtD
Acitretin—Vasculitis—Azathioprine—Crohn's disease	0.00164	0.00604	CcSEcCtD
Acitretin—Protein urine present—Mesalazine—Crohn's disease	0.00164	0.00603	CcSEcCtD
Acitretin—Bone disorder—Mesalazine—Crohn's disease	0.00162	0.00594	CcSEcCtD
Acitretin—Arthropathy—Mesalazine—Crohn's disease	0.00161	0.0059	CcSEcCtD
Acitretin—Pancytopenia—Mercaptopurine—Crohn's disease	0.0016	0.00589	CcSEcCtD
Acitretin—Embolism venous—Prednisone—Crohn's disease	0.00153	0.00563	CcSEcCtD
Acitretin—Stomatitis—Mercaptopurine—Crohn's disease	0.00147	0.00539	CcSEcCtD
Acitretin—Melaena—Mesalazine—Crohn's disease	0.00143	0.00524	CcSEcCtD
Acitretin—Influenza like illness—Mesalazine—Crohn's disease	0.00142	0.00521	CcSEcCtD
Acitretin—Candida infection—Mesalazine—Crohn's disease	0.00139	0.00513	CcSEcCtD
Acitretin—Skin exfoliation—Mesalazine—Crohn's disease	0.00139	0.00513	CcSEcCtD
Acitretin—Dry eye—Mesalazine—Crohn's disease	0.00135	0.00496	CcSEcCtD
Acitretin—Hypertriglyceridaemia—Prednisone—Crohn's disease	0.00135	0.00495	CcSEcCtD
Acitretin—Cramps of lower extremities—Mesalazine—Crohn's disease	0.00134	0.00493	CcSEcCtD
Acitretin—Hepatic function abnormal—Azathioprine—Crohn's disease	0.00133	0.0049	CcSEcCtD
Acitretin—Mouth ulceration—Mesalazine—Crohn's disease	0.00132	0.00485	CcSEcCtD
Acitretin—Febrile neutropenia—Prednisone—Crohn's disease	0.00128	0.00472	CcSEcCtD
Acitretin—Hypertonia—Mesalazine—Crohn's disease	0.00128	0.00471	CcSEcCtD
Acitretin—Optic neuritis—Prednisone—Crohn's disease	0.00126	0.00462	CcSEcCtD
Acitretin—RXRA—a6b1 and a6b4 Integrin signaling—MST1—Crohn's disease	0.00125	0.0337	CbGpPWpGaD
Acitretin—Ear pain—Mesalazine—Crohn's disease	0.00124	0.00457	CcSEcCtD
Acitretin—Immune system disorder—Mercaptopurine—Crohn's disease	0.00122	0.00449	CcSEcCtD
Acitretin—Photosensitivity—Mesalazine—Crohn's disease	0.00121	0.00444	CcSEcCtD
Acitretin—Embolism—Prednisone—Crohn's disease	0.0012	0.00442	CcSEcCtD
Acitretin—Gastroenteritis—Mesalazine—Crohn's disease	0.0012	0.0044	CcSEcCtD
Acitretin—Alopecia—Mercaptopurine—Crohn's disease	0.00119	0.00439	CcSEcCtD
Acitretin—Deafness—Mesalazine—Crohn's disease	0.00119	0.00436	CcSEcCtD
Acitretin—Eczema—Mesalazine—Crohn's disease	0.00118	0.00434	CcSEcCtD
Acitretin—Blood triglycerides increased—Prednisone—Crohn's disease	0.00118	0.00433	CcSEcCtD
Acitretin—Eye pain—Mesalazine—Crohn's disease	0.00117	0.00432	CcSEcCtD
Acitretin—Libido decreased—Mesalazine—Crohn's disease	0.00114	0.0042	CcSEcCtD
Acitretin—Increased appetite—Mesalazine—Crohn's disease	0.00113	0.00415	CcSEcCtD
Acitretin—Thirst—Mesalazine—Crohn's disease	0.00111	0.00409	CcSEcCtD
Acitretin—Dermatitis bullous—Mesalazine—Crohn's disease	0.00111	0.00408	CcSEcCtD
Acitretin—Suicidal ideation—Prednisone—Crohn's disease	0.0011	0.00405	CcSEcCtD
Acitretin—Myopathy—Prednisone—Crohn's disease	0.0011	0.00405	CcSEcCtD
Acitretin—Arthritis—Mesalazine—Crohn's disease	0.00109	0.00401	CcSEcCtD
Acitretin—Osteoarthritis—Mesalazine—Crohn's disease	0.00106	0.0039	CcSEcCtD
Acitretin—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.00105	0.00387	CcSEcCtD
Acitretin—Migraine—Mesalazine—Crohn's disease	0.00104	0.00384	CcSEcCtD
Acitretin—Neuritis—Prednisone—Crohn's disease	0.00104	0.0038	CcSEcCtD
Acitretin—Arthralgia—Mercaptopurine—Crohn's disease	0.001	0.00368	CcSEcCtD
Acitretin—Fungal infection—Prednisone—Crohn's disease	0.001	0.00368	CcSEcCtD
Acitretin—Blood creatinine increased—Mesalazine—Crohn's disease	0.000993	0.00365	CcSEcCtD
Acitretin—ALB—lymph node—Crohn's disease	0.000991	0.015	CbGeAlD
Acitretin—Pancreatitis—Azathioprine—Crohn's disease	0.000986	0.00363	CcSEcCtD
Acitretin—Liver function test abnormal—Mesalazine—Crohn's disease	0.000979	0.0036	CcSEcCtD
Acitretin—Dry skin—Mesalazine—Crohn's disease	0.000972	0.00357	CcSEcCtD
Acitretin—Oedema—Mercaptopurine—Crohn's disease	0.00096	0.00353	CcSEcCtD
Acitretin—Pancytopenia—Azathioprine—Crohn's disease	0.000955	0.00351	CcSEcCtD
Acitretin—Glycosuria—Prednisone—Crohn's disease	0.000954	0.00351	CcSEcCtD
Acitretin—Gastritis—Mesalazine—Crohn's disease	0.000938	0.00345	CcSEcCtD
Acitretin—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.000935	0.00344	CcSEcCtD
Acitretin—Skin disorder—Mercaptopurine—Crohn's disease	0.000933	0.00343	CcSEcCtD
Acitretin—Acne—Prednisone—Crohn's disease	0.000918	0.00338	CcSEcCtD
Acitretin—Anorexia—Mercaptopurine—Crohn's disease	0.000915	0.00336	CcSEcCtD
Acitretin—Pancreatitis—Mesalazine—Crohn's disease	0.000899	0.0033	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000875	0.00322	CcSEcCtD
Acitretin—Pancytopenia—Mesalazine—Crohn's disease	0.00087	0.0032	CcSEcCtD
Acitretin—Dysuria—Mesalazine—Crohn's disease	0.000857	0.00315	CcSEcCtD
Acitretin—Arthropathy—Prednisone—Crohn's disease	0.00085	0.00312	CcSEcCtD
Acitretin—Photosensitivity reaction—Mesalazine—Crohn's disease	0.000837	0.00307	CcSEcCtD
Acitretin—Decreased appetite—Mercaptopurine—Crohn's disease	0.000835	0.00307	CcSEcCtD
Acitretin—Weight increased—Mesalazine—Crohn's disease	0.000834	0.00307	CcSEcCtD
Acitretin—Weight decreased—Mesalazine—Crohn's disease	0.000829	0.00305	CcSEcCtD
Acitretin—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000829	0.00305	CcSEcCtD
Acitretin—Hypercholesterolaemia—Prednisone—Crohn's disease	0.000817	0.003	CcSEcCtD
Acitretin—Depression—Mesalazine—Crohn's disease	0.000815	0.00299	CcSEcCtD
Acitretin—Cataract—Prednisone—Crohn's disease	0.000812	0.00298	CcSEcCtD
Acitretin—Haemoglobin—Azathioprine—Crohn's disease	0.000809	0.00297	CcSEcCtD
Acitretin—Haemorrhage—Azathioprine—Crohn's disease	0.000805	0.00296	CcSEcCtD
Acitretin—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000801	0.00294	CcSEcCtD
Acitretin—Stomatitis—Mesalazine—Crohn's disease	0.000796	0.00293	CcSEcCtD
Acitretin—Jaundice—Mesalazine—Crohn's disease	0.000796	0.00293	CcSEcCtD
Acitretin—Urinary tract infection—Mesalazine—Crohn's disease	0.000794	0.00292	CcSEcCtD
Acitretin—Conjunctivitis—Mesalazine—Crohn's disease	0.000794	0.00292	CcSEcCtD
Acitretin—Vasculitis—Prednisone—Crohn's disease	0.000792	0.00291	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.000789	0.0212	CbGpPWpGaD
Acitretin—Haematuria—Mesalazine—Crohn's disease	0.000779	0.00286	CcSEcCtD
Acitretin—Epistaxis—Mesalazine—Crohn's disease	0.000771	0.00283	CcSEcCtD
Acitretin—Sinusitis—Mesalazine—Crohn's disease	0.000767	0.00282	CcSEcCtD
Acitretin—CYP26A1—Metapathway biotransformation—GPX4—Crohn's disease	0.000759	0.0204	CbGpPWpGaD
Acitretin—Body temperature increased—Mercaptopurine—Crohn's disease	0.000759	0.00279	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.000756	0.0204	CbGpPWpGaD
Acitretin—Skin exfoliation—Prednisone—Crohn's disease	0.000738	0.00271	CcSEcCtD
Acitretin—Haemoglobin—Mesalazine—Crohn's disease	0.000737	0.00271	CcSEcCtD
Acitretin—Rhinitis—Mesalazine—Crohn's disease	0.000735	0.0027	CcSEcCtD
Acitretin—Haemorrhage—Mesalazine—Crohn's disease	0.000734	0.0027	CcSEcCtD
Acitretin—Hepatitis—Mesalazine—Crohn's disease	0.000734	0.0027	CcSEcCtD
Acitretin—Pharyngitis—Mesalazine—Crohn's disease	0.000728	0.00268	CcSEcCtD
Acitretin—Immune system disorder—Azathioprine—Crohn's disease	0.000727	0.00267	CcSEcCtD
Acitretin—Oedema peripheral—Mesalazine—Crohn's disease	0.000723	0.00266	CcSEcCtD
Acitretin—Chills—Azathioprine—Crohn's disease	0.000723	0.00266	CcSEcCtD
Acitretin—Alopecia—Azathioprine—Crohn's disease	0.000712	0.00262	CcSEcCtD
Acitretin—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000707	0.0026	CcSEcCtD
Acitretin—Oesophagitis—Prednisone—Crohn's disease	0.000706	0.0026	CcSEcCtD
Acitretin—Eye disorder—Mesalazine—Crohn's disease	0.000686	0.00252	CcSEcCtD
Acitretin—Tinnitus—Mesalazine—Crohn's disease	0.000684	0.00251	CcSEcCtD
Acitretin—Angiopathy—Mesalazine—Crohn's disease	0.000666	0.00245	CcSEcCtD
Acitretin—Immune system disorder—Mesalazine—Crohn's disease	0.000663	0.00243	CcSEcCtD
Acitretin—Chills—Mesalazine—Crohn's disease	0.000658	0.00242	CcSEcCtD
Acitretin—Diarrhoea—Mercaptopurine—Crohn's disease	0.000657	0.00241	CcSEcCtD
Acitretin—Ill-defined disorder—Azathioprine—Crohn's disease	0.00065	0.00239	CcSEcCtD
Acitretin—Alopecia—Mesalazine—Crohn's disease	0.000648	0.00238	CcSEcCtD
Acitretin—Diabetes mellitus—Prednisone—Crohn's disease	0.000645	0.00237	CcSEcCtD
Acitretin—Erythema—Mesalazine—Crohn's disease	0.000639	0.00235	CcSEcCtD
Acitretin—Malaise—Azathioprine—Crohn's disease	0.000632	0.00232	CcSEcCtD
Acitretin—Vascular purpura—Prednisone—Crohn's disease	0.000627	0.0023	CcSEcCtD
Acitretin—Tension—Mesalazine—Crohn's disease	0.000627	0.0023	CcSEcCtD
Acitretin—Dysgeusia—Mesalazine—Crohn's disease	0.000625	0.0023	CcSEcCtD
Acitretin—Nervousness—Mesalazine—Crohn's disease	0.00062	0.00228	CcSEcCtD
Acitretin—Back pain—Mesalazine—Crohn's disease	0.000618	0.00227	CcSEcCtD
Acitretin—Muscle spasms—Mesalazine—Crohn's disease	0.000614	0.00226	CcSEcCtD
Acitretin—Vomiting—Mercaptopurine—Crohn's disease	0.000611	0.00224	CcSEcCtD
Acitretin—Rash—Mercaptopurine—Crohn's disease	0.000605	0.00222	CcSEcCtD
Acitretin—Dermatitis—Mercaptopurine—Crohn's disease	0.000605	0.00222	CcSEcCtD
Acitretin—Vision blurred—Mesalazine—Crohn's disease	0.000602	0.00221	CcSEcCtD
Acitretin—Increased appetite—Prednisone—Crohn's disease	0.000597	0.00219	CcSEcCtD
Acitretin—Arthralgia—Azathioprine—Crohn's disease	0.000597	0.00219	CcSEcCtD
Acitretin—Myalgia—Azathioprine—Crohn's disease	0.000597	0.00219	CcSEcCtD
Acitretin—Ill-defined disorder—Mesalazine—Crohn's disease	0.000592	0.00218	CcSEcCtD
Acitretin—Discomfort—Azathioprine—Crohn's disease	0.00059	0.00217	CcSEcCtD
Acitretin—RXRA—Recycling of bile acids and salts—ALB—Crohn's disease	0.000588	0.0158	CbGpPWpGaD
Acitretin—Angioedema—Mesalazine—Crohn's disease	0.000583	0.00214	CcSEcCtD
Acitretin—Purpura—Prednisone—Crohn's disease	0.000582	0.00214	CcSEcCtD
Acitretin—Malaise—Mesalazine—Crohn's disease	0.000576	0.00212	CcSEcCtD
Acitretin—Nausea—Mercaptopurine—Crohn's disease	0.00057	0.0021	CcSEcCtD
Acitretin—Infection—Azathioprine—Crohn's disease	0.000568	0.00209	CcSEcCtD
Acitretin—Osteoarthritis—Prednisone—Crohn's disease	0.000561	0.00206	CcSEcCtD
Acitretin—Cough—Mesalazine—Crohn's disease	0.000557	0.00205	CcSEcCtD
Acitretin—Skin disorder—Azathioprine—Crohn's disease	0.000556	0.00204	CcSEcCtD
Acitretin—Myalgia—Mesalazine—Crohn's disease	0.000544	0.002	CcSEcCtD
Acitretin—Arthralgia—Mesalazine—Crohn's disease	0.000544	0.002	CcSEcCtD
Acitretin—Chest pain—Mesalazine—Crohn's disease	0.000544	0.002	CcSEcCtD
Acitretin—Anxiety—Mesalazine—Crohn's disease	0.000542	0.00199	CcSEcCtD
Acitretin—Discomfort—Mesalazine—Crohn's disease	0.000537	0.00197	CcSEcCtD
Acitretin—Dry mouth—Mesalazine—Crohn's disease	0.000532	0.00195	CcSEcCtD
Acitretin—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—Crohn's disease	0.000525	0.0141	CbGpPWpGaD
Acitretin—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000521	0.00192	CcSEcCtD
Acitretin—Oedema—Mesalazine—Crohn's disease	0.000521	0.00192	CcSEcCtD
Acitretin—Infection—Mesalazine—Crohn's disease	0.000518	0.0019	CcSEcCtD
Acitretin—Dry skin—Prednisone—Crohn's disease	0.000514	0.00189	CcSEcCtD
Acitretin—CYP26A1—Adipogenesis—SOCS1—Crohn's disease	0.000512	0.0138	CbGpPWpGaD
Acitretin—Skin disorder—Mesalazine—Crohn's disease	0.000506	0.00186	CcSEcCtD
Acitretin—Hyperhidrosis—Mesalazine—Crohn's disease	0.000504	0.00185	CcSEcCtD
Acitretin—Anorexia—Mesalazine—Crohn's disease	0.000497	0.00183	CcSEcCtD
Acitretin—Muscular weakness—Prednisone—Crohn's disease	0.000495	0.00182	CcSEcCtD
Acitretin—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.000495	0.00182	CcSEcCtD
Acitretin—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000494	0.00182	CcSEcCtD
Acitretin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TNF—Crohn's disease	0.00048	0.0129	CbGpPWpGaD
Acitretin—Pancreatitis—Prednisone—Crohn's disease	0.000475	0.00175	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000475	0.00174	CcSEcCtD
Acitretin—Sweating increased—Prednisone—Crohn's disease	0.000472	0.00174	CcSEcCtD
Acitretin—Feeling abnormal—Azathioprine—Crohn's disease	0.000471	0.00173	CcSEcCtD
Acitretin—Insomnia—Mesalazine—Crohn's disease	0.000471	0.00173	CcSEcCtD
Acitretin—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—Crohn's disease	0.000471	0.0127	CbGpPWpGaD
Acitretin—Paraesthesia—Mesalazine—Crohn's disease	0.000468	0.00172	CcSEcCtD
Acitretin—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000468	0.00172	CcSEcCtD
Acitretin—Somnolence—Mesalazine—Crohn's disease	0.000463	0.0017	CcSEcCtD
Acitretin—Dyspepsia—Mesalazine—Crohn's disease	0.000459	0.00169	CcSEcCtD
Acitretin—Decreased appetite—Mesalazine—Crohn's disease	0.000453	0.00166	CcSEcCtD
Acitretin—Body temperature increased—Azathioprine—Crohn's disease	0.000452	0.00166	CcSEcCtD
Acitretin—Abdominal pain—Azathioprine—Crohn's disease	0.000452	0.00166	CcSEcCtD
Acitretin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—Crohn's disease	0.000452	0.0122	CbGpPWpGaD
Acitretin—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—Crohn's disease	0.000452	0.0122	CbGpPWpGaD
Acitretin—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00045	0.00165	CcSEcCtD
Acitretin—Fatigue—Mesalazine—Crohn's disease	0.000449	0.00165	CcSEcCtD
Acitretin—Erectile dysfunction—Prednisone—Crohn's disease	0.000447	0.00164	CcSEcCtD
Acitretin—Constipation—Mesalazine—Crohn's disease	0.000446	0.00164	CcSEcCtD
Acitretin—Pain—Mesalazine—Crohn's disease	0.000446	0.00164	CcSEcCtD
Acitretin—CYP26A1—Adipogenesis—SMAD3—Crohn's disease	0.000442	0.0119	CbGpPWpGaD
Acitretin—Weight increased—Prednisone—Crohn's disease	0.000441	0.00162	CcSEcCtD
Acitretin—Weight decreased—Prednisone—Crohn's disease	0.000439	0.00161	CcSEcCtD
Acitretin—RXRA—PPARA activates gene expression—FADS1—Crohn's disease	0.000437	0.0118	CbGpPWpGaD
Acitretin—Depression—Prednisone—Crohn's disease	0.000431	0.00158	CcSEcCtD
Acitretin—Feeling abnormal—Mesalazine—Crohn's disease	0.000429	0.00158	CcSEcCtD
Acitretin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—FADS1—Crohn's disease	0.000427	0.0115	CbGpPWpGaD
Acitretin—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000426	0.00157	CcSEcCtD
Acitretin—Neuropathy peripheral—Prednisone—Crohn's disease	0.000424	0.00156	CcSEcCtD
Acitretin—Hypersensitivity—Azathioprine—Crohn's disease	0.000422	0.00155	CcSEcCtD
Acitretin—Urticaria—Mesalazine—Crohn's disease	0.000414	0.00152	CcSEcCtD
Acitretin—Body temperature increased—Mesalazine—Crohn's disease	0.000412	0.00151	CcSEcCtD
Acitretin—Abdominal pain—Mesalazine—Crohn's disease	0.000412	0.00151	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.000394	0.0106	CbGpPWpGaD
Acitretin—Diarrhoea—Azathioprine—Crohn's disease	0.000391	0.00144	CcSEcCtD
Acitretin—Haemoglobin—Prednisone—Crohn's disease	0.00039	0.00143	CcSEcCtD
Acitretin—RXRG—Adipogenesis—SOCS1—Crohn's disease	0.000388	0.0105	CbGpPWpGaD
Acitretin—Haemorrhage—Prednisone—Crohn's disease	0.000388	0.00143	CcSEcCtD
Acitretin—Hypersensitivity—Mesalazine—Crohn's disease	0.000384	0.00141	CcSEcCtD
Acitretin—Dizziness—Azathioprine—Crohn's disease	0.000378	0.00139	CcSEcCtD
Acitretin—Asthenia—Mesalazine—Crohn's disease	0.000374	0.00137	CcSEcCtD
Acitretin—Pruritus—Mesalazine—Crohn's disease	0.000369	0.00136	CcSEcCtD
Acitretin—RARA—Adipogenesis—SOCS1—Crohn's disease	0.000365	0.00983	CbGpPWpGaD
Acitretin—Vomiting—Azathioprine—Crohn's disease	0.000364	0.00134	CcSEcCtD
Acitretin—Eye disorder—Prednisone—Crohn's disease	0.000363	0.00133	CcSEcCtD
Acitretin—Rash—Azathioprine—Crohn's disease	0.000361	0.00133	CcSEcCtD
Acitretin—Dermatitis—Azathioprine—Crohn's disease	0.00036	0.00132	CcSEcCtD
Acitretin—Flushing—Prednisone—Crohn's disease	0.00036	0.00132	CcSEcCtD
Acitretin—Headache—Azathioprine—Crohn's disease	0.000358	0.00132	CcSEcCtD
Acitretin—Diarrhoea—Mesalazine—Crohn's disease	0.000357	0.00131	CcSEcCtD
Acitretin—Angiopathy—Prednisone—Crohn's disease	0.000352	0.00129	CcSEcCtD
Acitretin—Immune system disorder—Prednisone—Crohn's disease	0.000351	0.00129	CcSEcCtD
Acitretin—Dizziness—Mesalazine—Crohn's disease	0.000345	0.00127	CcSEcCtD
Acitretin—Alopecia—Prednisone—Crohn's disease	0.000343	0.00126	CcSEcCtD
Acitretin—Nausea—Azathioprine—Crohn's disease	0.00034	0.00125	CcSEcCtD
Acitretin—Erythema—Prednisone—Crohn's disease	0.000338	0.00124	CcSEcCtD
Acitretin—RXRG—Adipogenesis—SMAD3—Crohn's disease	0.000335	0.00903	CbGpPWpGaD
Acitretin—Vomiting—Mesalazine—Crohn's disease	0.000331	0.00122	CcSEcCtD
Acitretin—Rash—Mesalazine—Crohn's disease	0.000329	0.00121	CcSEcCtD
Acitretin—Dermatitis—Mesalazine—Crohn's disease	0.000328	0.00121	CcSEcCtD
Acitretin—Headache—Mesalazine—Crohn's disease	0.000326	0.0012	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.000319	0.0086	CbGpPWpGaD
Acitretin—Vision blurred—Prednisone—Crohn's disease	0.000318	0.00117	CcSEcCtD
Acitretin—RARA—Adipogenesis—SMAD3—Crohn's disease	0.000315	0.00849	CbGpPWpGaD
Acitretin—Ill-defined disorder—Prednisone—Crohn's disease	0.000313	0.00115	CcSEcCtD
Acitretin—Nausea—Mesalazine—Crohn's disease	0.00031	0.00114	CcSEcCtD
Acitretin—Angioedema—Prednisone—Crohn's disease	0.000309	0.00113	CcSEcCtD
Acitretin—RXRA—Bile acid and bile salt metabolism—ALB—Crohn's disease	0.000307	0.00827	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.000306	0.00824	CbGpPWpGaD
Acitretin—Malaise—Prednisone—Crohn's disease	0.000305	0.00112	CcSEcCtD
Acitretin—RARG—Gene Expression—PTRF—Crohn's disease	0.000299	0.00804	CbGpPWpGaD
Acitretin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—FADS1—Crohn's disease	0.000294	0.00793	CbGpPWpGaD
Acitretin—Myalgia—Prednisone—Crohn's disease	0.000288	0.00106	CcSEcCtD
Acitretin—Arthralgia—Prednisone—Crohn's disease	0.000288	0.00106	CcSEcCtD
Acitretin—Anxiety—Prednisone—Crohn's disease	0.000287	0.00105	CcSEcCtD
Acitretin—Discomfort—Prednisone—Crohn's disease	0.000284	0.00104	CcSEcCtD
Acitretin—ALB—Folate Metabolism—GPX4—Crohn's disease	0.000281	0.00756	CbGpPWpGaD
Acitretin—Oedema—Prednisone—Crohn's disease	0.000276	0.00101	CcSEcCtD
Acitretin—Infection—Prednisone—Crohn's disease	0.000274	0.00101	CcSEcCtD
Acitretin—RXRG—Gene Expression—PTRF—Crohn's disease	0.000273	0.00735	CbGpPWpGaD
Acitretin—RBP1—Disease—RSPO3—Crohn's disease	0.000272	0.00732	CbGpPWpGaD
Acitretin—RXRA—Transcription factor regulation in adipogenesis—TNF—Crohn's disease	0.000269	0.00724	CbGpPWpGaD
Acitretin—Skin disorder—Prednisone—Crohn's disease	0.000268	0.000984	CcSEcCtD
Acitretin—RARB—Gene Expression—PTRF—Crohn's disease	0.000268	0.00721	CbGpPWpGaD
Acitretin—Hyperhidrosis—Prednisone—Crohn's disease	0.000267	0.00098	CcSEcCtD
Acitretin—ALB—Vitamin B12 Metabolism—MPO—Crohn's disease	0.000263	0.00708	CbGpPWpGaD
Acitretin—Anorexia—Prednisone—Crohn's disease	0.000263	0.000966	CcSEcCtD
Acitretin—RBP1—Disease—SEL1L—Crohn's disease	0.000258	0.00694	CbGpPWpGaD
Acitretin—RARA—Gene Expression—PTRF—Crohn's disease	0.000257	0.00691	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—PTRF—Crohn's disease	0.000257	0.00691	CbGpPWpGaD
Acitretin—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000251	0.000923	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—ACKR2—Crohn's disease	0.000251	0.00676	CbGpPWpGaD
Acitretin—Insomnia—Prednisone—Crohn's disease	0.000249	0.000917	CcSEcCtD
Acitretin—Paraesthesia—Prednisone—Crohn's disease	0.000248	0.00091	CcSEcCtD
Acitretin—ALB—Platelet degranulation—F5—Crohn's disease	0.000244	0.00656	CbGpPWpGaD
Acitretin—Dyspepsia—Prednisone—Crohn's disease	0.000243	0.000892	CcSEcCtD
Acitretin—Decreased appetite—Prednisone—Crohn's disease	0.00024	0.000881	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—MLN—Crohn's disease	0.000238	0.00641	CbGpPWpGaD
Acitretin—Fatigue—Prednisone—Crohn's disease	0.000238	0.000874	CcSEcCtD
Acitretin—Constipation—Prednisone—Crohn's disease	0.000236	0.000867	CcSEcCtD
Acitretin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—Crohn's disease	0.000235	0.00634	CbGpPWpGaD
Acitretin—ALB—Response to elevated platelet cytosolic Ca2+—F5—Crohn's disease	0.000232	0.00625	CbGpPWpGaD
Acitretin—RBP1—Disease—LTF—Crohn's disease	0.000231	0.00622	CbGpPWpGaD
Acitretin—Feeling abnormal—Prednisone—Crohn's disease	0.000227	0.000835	CcSEcCtD
Acitretin—Gastrointestinal pain—Prednisone—Crohn's disease	0.000225	0.000829	CcSEcCtD
Acitretin—ALB—Selenium Micronutrient Network—GPX4—Crohn's disease	0.000223	0.006	CbGpPWpGaD
Acitretin—Urticaria—Prednisone—Crohn's disease	0.000219	0.000805	CcSEcCtD
Acitretin—Body temperature increased—Prednisone—Crohn's disease	0.000218	0.000801	CcSEcCtD
Acitretin—Abdominal pain—Prednisone—Crohn's disease	0.000218	0.000801	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—TAGAP—Crohn's disease	0.000218	0.00586	CbGpPWpGaD
Acitretin—RXRA—Transcription factor regulation in adipogenesis—IL6—Crohn's disease	0.000217	0.00584	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—MPO—Crohn's disease	0.000214	0.00576	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PLA2G4F—Crohn's disease	0.000212	0.00572	CbGpPWpGaD
Acitretin—Hypersensitivity—Prednisone—Crohn's disease	0.000203	0.000747	CcSEcCtD
Acitretin—CYP26A1—Adipogenesis—STAT3—Crohn's disease	0.000202	0.00544	CbGpPWpGaD
Acitretin—Asthenia—Prednisone—Crohn's disease	0.000198	0.000727	CcSEcCtD
Acitretin—Pruritus—Prednisone—Crohn's disease	0.000195	0.000717	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—RSPO3—Crohn's disease	0.00019	0.00512	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—SOCS1—Crohn's disease	0.00019	0.00512	CbGpPWpGaD
Acitretin—Diarrhoea—Prednisone—Crohn's disease	0.000189	0.000693	CcSEcCtD
Acitretin—RARG—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.000187	0.00504	CbGpPWpGaD
Acitretin—RBP1—Disease—GCKR—Crohn's disease	0.000186	0.00502	CbGpPWpGaD
Acitretin—Dizziness—Prednisone—Crohn's disease	0.000182	0.00067	CcSEcCtD
Acitretin—CYP26A1—Metabolism—MTMR3—Crohn's disease	0.000181	0.00486	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—SEL1L—Crohn's disease	0.00018	0.00486	CbGpPWpGaD
Acitretin—RARG—Gene Expression—ZFP36L1—Crohn's disease	0.000179	0.00481	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000177	0.00477	CbGpPWpGaD
Acitretin—Vomiting—Prednisone—Crohn's disease	0.000175	0.000644	CcSEcCtD
Acitretin—CYP26A1—Adipogenesis—TNF—Crohn's disease	0.000175	0.00471	CbGpPWpGaD
Acitretin—Rash—Prednisone—Crohn's disease	0.000174	0.000639	CcSEcCtD
Acitretin—Dermatitis—Prednisone—Crohn's disease	0.000174	0.000638	CcSEcCtD
Acitretin—Headache—Prednisone—Crohn's disease	0.000173	0.000635	CcSEcCtD
Acitretin—RXRG—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.000171	0.00461	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—MPO—Crohn's disease	0.00017	0.00458	CbGpPWpGaD
Acitretin—RARB—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.000168	0.00452	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CCR9—Crohn's disease	0.000165	0.00444	CbGpPWpGaD
Acitretin—RBP1—Disease—SLC11A1—Crohn's disease	0.000165	0.00443	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—SMAD3—Crohn's disease	0.000164	0.00442	CbGpPWpGaD
Acitretin—Nausea—Prednisone—Crohn's disease	0.000164	0.000602	CcSEcCtD
Acitretin—RXRG—Gene Expression—ZFP36L1—Crohn's disease	0.000164	0.0044	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.000161	0.00433	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.000161	0.00433	CbGpPWpGaD
Acitretin—RARB—Gene Expression—ZFP36L1—Crohn's disease	0.00016	0.00432	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.00016	0.0043	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—ZFP36L1—Crohn's disease	0.000154	0.00414	CbGpPWpGaD
Acitretin—RARA—Gene Expression—ZFP36L1—Crohn's disease	0.000154	0.00414	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—GPR65—Crohn's disease	0.000153	0.00413	CbGpPWpGaD
Acitretin—RXRG—Adipogenesis—STAT3—Crohn's disease	0.000153	0.00412	CbGpPWpGaD
Acitretin—RARG—Gene Expression—DNMT3A—Crohn's disease	0.000152	0.00409	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000151	0.00405	CbGpPWpGaD
Acitretin—RARA—Adipogenesis—STAT3—Crohn's disease	0.000144	0.00388	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000143	0.00385	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000143	0.00385	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	0.000142	0.00381	CbGpPWpGaD
Acitretin—RBP1—Disease—RBX1—Crohn's disease	0.000141	0.0038	CbGpPWpGaD
Acitretin—RBP1—Disease—HSPA1B—Crohn's disease	0.000141	0.0038	CbGpPWpGaD
Acitretin—CYP26A1—Adipogenesis—IL6—Crohn's disease	0.000141	0.0038	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—FADS1—Crohn's disease	0.000141	0.00379	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—DNMT3A—Crohn's disease	0.000139	0.00374	CbGpPWpGaD
Acitretin—ALB—Vitamin B12 Metabolism—CRP—Crohn's disease	0.000138	0.00372	CbGpPWpGaD
Acitretin—RARB—Gene Expression—DNMT3A—Crohn's disease	0.000136	0.00367	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	0.000136	0.00365	CbGpPWpGaD
Acitretin—RARG—Generic Transcription Pathway—SMAD3—Crohn's disease	0.000134	0.0036	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—PTRF—Crohn's disease	0.000134	0.0036	CbGpPWpGaD
Acitretin—RXRG—Adipogenesis—TNF—Crohn's disease	0.000133	0.00357	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—GPX4—Crohn's disease	0.000132	0.00355	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—DNMT3A—Crohn's disease	0.000131	0.00352	CbGpPWpGaD
Acitretin—RARA—Gene Expression—DNMT3A—Crohn's disease	0.000131	0.00352	CbGpPWpGaD
Acitretin—ALB—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000128	0.00346	CbGpPWpGaD
Acitretin—ALB—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000128	0.00346	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—GCKR—Crohn's disease	0.000127	0.00342	CbGpPWpGaD
Acitretin—ALB—Vitamin B12 Metabolism—ICAM1—Crohn's disease	0.000127	0.00342	CbGpPWpGaD
Acitretin—RARA—Adipogenesis—TNF—Crohn's disease	0.000125	0.00336	CbGpPWpGaD
Acitretin—RBP1—Disease—UBE2D1—Crohn's disease	0.000124	0.00333	CbGpPWpGaD
Acitretin—RXRG—Generic Transcription Pathway—SMAD3—Crohn's disease	0.000122	0.0033	CbGpPWpGaD
Acitretin—RARB—Generic Transcription Pathway—SMAD3—Crohn's disease	0.00012	0.00323	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000117	0.00316	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—SMAD3—Crohn's disease	0.000115	0.0031	CbGpPWpGaD
Acitretin—RARA—Generic Transcription Pathway—SMAD3—Crohn's disease	0.000115	0.0031	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—CRP—Crohn's disease	0.000113	0.00303	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.00011	0.00296	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CCR6—Crohn's disease	0.000109	0.00294	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—F5—Crohn's disease	0.000108	0.00291	CbGpPWpGaD
Acitretin—RXRG—Adipogenesis—IL6—Crohn's disease	0.000107	0.00288	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—ICAM1—Crohn's disease	0.000103	0.00279	CbGpPWpGaD
Acitretin—RARG—Gene Expression—HSPA1B—Crohn's disease	0.000103	0.00277	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000101	0.00271	CbGpPWpGaD
Acitretin—RARA—Adipogenesis—IL6—Crohn's disease	0.000101	0.00271	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—RBX1—Crohn's disease	9.89e-05	0.00266	CbGpPWpGaD
Acitretin—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—Crohn's disease	9.87e-05	0.00266	CbGpPWpGaD
Acitretin—ALB—Vitamin B12 Metabolism—IFNG—Crohn's disease	9.68e-05	0.0026	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PTGER4—Crohn's disease	9.62e-05	0.00259	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	9.55e-05	0.00257	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—HSPA1B—Crohn's disease	9.39e-05	0.00253	CbGpPWpGaD
Acitretin—RARB—Gene Expression—HSPA1B—Crohn's disease	9.21e-05	0.00248	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	9.16e-05	0.00247	CbGpPWpGaD
Acitretin—ALB—SLC-mediated transmembrane transport—GCKR—Crohn's disease	9.05e-05	0.00244	CbGpPWpGaD
Acitretin—RARG—Gene Expression—UBE2D1—Crohn's disease	9.01e-05	0.00242	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—CRP—Crohn's disease	8.94e-05	0.00241	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	8.91e-05	0.0024	CbGpPWpGaD
Acitretin—RBP1—Disease—SMAD3—Crohn's disease	8.86e-05	0.00238	CbGpPWpGaD
Acitretin—RARA—Gene Expression—HSPA1B—Crohn's disease	8.83e-05	0.00238	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—HSPA1B—Crohn's disease	8.83e-05	0.00238	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—UBE2D1—Crohn's disease	8.67e-05	0.00233	CbGpPWpGaD
Acitretin—ALB—Vitamin B12 Metabolism—IL1B—Crohn's disease	8.63e-05	0.00232	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—RIPK2—Crohn's disease	8.41e-05	0.00226	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—UBE2D1—Crohn's disease	8.38e-05	0.00226	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—UBE2D1—Crohn's disease	8.24e-05	0.00222	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—ICAM1—Crohn's disease	8.22e-05	0.00221	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IL3—Crohn's disease	8.2e-05	0.00221	CbGpPWpGaD
Acitretin—RARB—Gene Expression—UBE2D1—Crohn's disease	8.08e-05	0.00218	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	8.07e-05	0.00217	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—ZFP36L1—Crohn's disease	8.01e-05	0.00216	CbGpPWpGaD
Acitretin—ALB—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	8e-05	0.00215	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—RASGRP1—Crohn's disease	7.93e-05	0.00213	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PLA2G4F—Crohn's disease	7.88e-05	0.00212	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—IFNG—Crohn's disease	7.87e-05	0.00212	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—UBE2D1—Crohn's disease	7.75e-05	0.00209	CbGpPWpGaD
Acitretin—RARA—Gene Expression—UBE2D1—Crohn's disease	7.75e-05	0.00209	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—STAT3—Crohn's disease	7.5e-05	0.00202	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—SOCS1—Crohn's disease	7.18e-05	0.00193	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	7.07e-05	0.0019	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—IL1B—Crohn's disease	7.02e-05	0.00189	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	6.87e-05	0.00185	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—DNMT3A—Crohn's disease	6.81e-05	0.00183	CbGpPWpGaD
Acitretin—RXRA—Metabolism—MTMR3—Crohn's disease	6.7e-05	0.0018	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	6.53e-05	0.00176	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	6.53e-05	0.00176	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—TNF—Crohn's disease	6.49e-05	0.00175	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—IL3—Crohn's disease	6.48e-05	0.00174	CbGpPWpGaD
Acitretin—RARG—Gene Expression—SMAD3—Crohn's disease	6.44e-05	0.00173	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—RASGRP1—Crohn's disease	6.26e-05	0.00169	CbGpPWpGaD
Acitretin—ALB—Vitamin B12 Metabolism—TNF—Crohn's disease	6.26e-05	0.00169	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—IFNG—Crohn's disease	6.25e-05	0.00168	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—SMAD3—Crohn's disease	6.2e-05	0.00167	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—SMAD3—Crohn's disease	6e-05	0.00161	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—PTGS2—Crohn's disease	6e-05	0.00161	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—SMAD3—Crohn's disease	5.89e-05	0.00159	CbGpPWpGaD
Acitretin—RARB—Gene Expression—SMAD3—Crohn's disease	5.78e-05	0.00156	CbGpPWpGaD
Acitretin—RBP1—Disease—TYK2—Crohn's disease	5.78e-05	0.00156	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IL2RA—Crohn's disease	5.74e-05	0.00155	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—SMAD3—Crohn's disease	5.65e-05	0.00152	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—IL1B—Crohn's disease	5.58e-05	0.0015	CbGpPWpGaD
Acitretin—ALB—Hemostasis—F5—Crohn's disease	5.57e-05	0.0015	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—SMAD3—Crohn's disease	5.54e-05	0.00149	CbGpPWpGaD
Acitretin—RARA—Gene Expression—SMAD3—Crohn's disease	5.54e-05	0.00149	CbGpPWpGaD
Acitretin—RBP1—Disease—JAK2—Crohn's disease	5.51e-05	0.00148	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	5.35e-05	0.00144	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—IL6—Crohn's disease	5.24e-05	0.00141	CbGpPWpGaD
Acitretin—RBP1—Disease—CD4—Crohn's disease	5.23e-05	0.00141	CbGpPWpGaD
Acitretin—RXRA—Metabolism—FADS1—Crohn's disease	5.22e-05	0.00141	CbGpPWpGaD
Acitretin—RBP1—Disease—PTGS2—Crohn's disease	5.19e-05	0.0014	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—TNF—Crohn's disease	5.09e-05	0.00137	CbGpPWpGaD
Acitretin—ALB—Vitamin B12 Metabolism—IL6—Crohn's disease	5.05e-05	0.00136	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	5.01e-05	0.00135	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GPX4—Crohn's disease	4.89e-05	0.00132	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	4.77e-05	0.00129	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GCKR—Crohn's disease	4.72e-05	0.00127	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—HSPA1B—Crohn's disease	4.6e-05	0.00124	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—GCKR—Crohn's disease	4.6e-05	0.00124	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	4.54e-05	0.00122	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—IL6—Crohn's disease	4.11e-05	0.00111	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.07e-05	0.00109	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—ALB—Crohn's disease	4.05e-05	0.00109	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—TNF—Crohn's disease	4.05e-05	0.00109	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TYK2—Crohn's disease	4.05e-05	0.00109	CbGpPWpGaD
Acitretin—RBP1—Disease—STAT3—Crohn's disease	4.05e-05	0.00109	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—UBE2D1—Crohn's disease	4.04e-05	0.00109	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—JAK2—Crohn's disease	3.86e-05	0.00104	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—TYK2—Crohn's disease	3.68e-05	0.000992	CbGpPWpGaD
Acitretin—ALB—Metabolism—PLA2G4F—Crohn's disease	3.6e-05	0.000968	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PTGS2—Crohn's disease	3.54e-05	0.000953	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CXCL8—Crohn's disease	3.52e-05	0.000948	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—JAK2—Crohn's disease	3.51e-05	0.000946	CbGpPWpGaD
Acitretin—ALB—Hemostasis—ITGA4—Crohn's disease	3.42e-05	0.000922	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.38e-05	0.000909	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IL3—Crohn's disease	3.34e-05	0.000899	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—IL6—Crohn's disease	3.27e-05	0.000879	CbGpPWpGaD
Acitretin—ALB—Hemostasis—RASGRP1—Crohn's disease	3.23e-05	0.000869	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—ALB—Crohn's disease	3.21e-05	0.000864	CbGpPWpGaD
Acitretin—ALB—Metabolism—MTMR3—Crohn's disease	3.06e-05	0.000823	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	3.05e-05	0.000821	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.95e-05	0.000795	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—SMAD3—Crohn's disease	2.89e-05	0.000777	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—STAT3—Crohn's disease	2.83e-05	0.000763	CbGpPWpGaD
Acitretin—RBP1—Disease—IL6—Crohn's disease	2.83e-05	0.000761	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—STAT3—Crohn's disease	2.58e-05	0.000694	CbGpPWpGaD
Acitretin—ALB—Metabolism—FADS1—Crohn's disease	2.38e-05	0.000641	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IL2RA—Crohn's disease	2.34e-05	0.00063	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—TNF—Crohn's disease	2.23e-05	0.000601	CbGpPWpGaD
Acitretin—ALB—Metabolism—GPX4—Crohn's disease	2.23e-05	0.000601	CbGpPWpGaD
Acitretin—ALB—Metabolism—GCKR—Crohn's disease	2.15e-05	0.00058	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IL6—Crohn's disease	1.98e-05	0.000533	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—IL6—Crohn's disease	1.8e-05	0.000485	CbGpPWpGaD
Acitretin—ALB—Hemostasis—JAK2—Crohn's disease	1.57e-05	0.000423	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ALB—Crohn's disease	1.5e-05	0.000405	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.35e-05	0.000363	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PTGS2—Crohn's disease	1.32e-05	0.000354	CbGpPWpGaD
Acitretin—ALB—Metabolism—PTGS2—Crohn's disease	6e-06	0.000161	CbGpPWpGaD
